Home » Topics » Regulatory » Patents

Patents
RSS

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent AKT1/AKT2/AKT3 inhibitors

Oct. 11, 2021

Enanta Pharmaceuticals synthesizes new anti-HBV compounds

Oct. 11, 2021

BioWorld MedTech Patent Highlights: Week 39

From Current Patent Gazette

Oct. 8, 2021

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Sichuan Haisco Pharmaceutical describes new JAK inhibitors

Oct. 8, 2021

Merck KGaA and Ryvu Therapeutics divulge new ACSS2 inhibitors

Oct. 8, 2021

Evotec presents ISR pathway modulators

Oct. 8, 2021

Minghui Pharmaceutical scientists synthesize new JAK inhibitors

Oct. 8, 2021

AstraZeneca patents SLC12A5 activators

Oct. 8, 2021

Verge Analytics discovers new PIKfyve inhibitors

Oct. 7, 2021

Researchers synthesize new CDK inhibitors

Oct. 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...